Pursuant to Regulation 39(3) of the SEBI (LODR) Regulations, 2015 read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, Link Pharma Chem has informed that the Company has issued the letter of Confirmation in lieu of Duplicate share Certificate to the shareholder: Santosh Kumar Jain (Folio No: 0007954), further details enclosed.
The above information is a part of company’s filings submitted to BSE.